Fieldfisher advises pharmaceutical, biotechnology and medical technology companies, healthcare providers and medical technology start-ups on regulatory market entry for medical devices and pharmaceuticals, including related clinical trials, conformity assessment procedures and licensing issues, as well as on compliance and transactions. This mirrors the focus of practice head Cord Willhöft.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Excellent lawyers, who respond to the needs of customers and always find the right solution. Diverse dedicated teams that also offer a good balance of partners and associates.'
- 'Cord Willhöft: Proven expert in the life sciences sector; experienced, precise, pragmatic.'
Key clients
- Asahi Kasei Bioprocess
- Butterfly Networks, Inc.
- Corvia Medical
- Galvanize Therapeutics
- Ideaya Biosciences
- Jena Valve
- Medicaroid GmbH
- Priocept BioRobotics Inc.
- Procept BioRobotics Inc.
- Pulmonx Sarl und Pulmonx Co.
- ResMed GmbH & Co KG
- Starkey Inc.
- ZOLL CMS GmbH und ZOLL Medical Corporation
Work highlights
- Advising Pulmonx Sarl and Pulmonx Co on market access, healthcare compliance and sales as well as regulatory issues.
- General legal advice to ResMed GmbH & Co KG as well as advice on transactions and real estate.
- Legal and strategic advice to ZOLL CMS GmbH and ZOLL Medical Corporation on reimbursement of medical aids, healthcare compliance, contract drafting and data protection (GDPR).
Practice head
The lawyer(s) leading their teams.
Cord Willhöft